Test results
| Appearance | Good · Pass |
|---|---|
| Identity | Confirmed · HPLC · Pass |
| Net peptide content | 50.21 mg · HPLC · Report only |
| Sterility | No Growth · PCR · Pass |
| Endotoxins | <0.05 EU/mL · LAL · Spec ≤ 5 EU/mL · Pass |
| Heavy metals | All Below Limits · ICP-MS · USP <233> · Pass |
| Fentanyl screen | Not detected · Pass |
Batch details
| Product | Mirabegron (β₃ Adrenergic Agonist) |
|---|---|
| Batch / lot | MB01 |
| Certificate number | COA-2026-2XGF9T |
| Laboratory | ILS Laboratories (ISO/IEC 17025 accredited) |
| Tested | Aug 6, 2026 |
| Labeled amount | 50mg |
| Method | Full QC Panel |
| Lab verdict | PASS |
Original certificate
Open the image for the full-size report. Match the lot number printed on your vial to MB01. Every other batch of Mirabegron (β₃ Adrenergic Agonist) is listed on its product page.
New to certificates of analysis? What is a COA? explains the tests on this page and how labs check identity and purity.
Other batches of Mirabegron (β₃ Adrenergic Agonist)
- Batch MB01, tested Jul 15, 2026

